China National Accord Medicines Corp Ltd (000028) — Cash Flow-to-Debt Ratio
China National Accord Medicines Corp Ltd (000028) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2025, meaning its operating cash flow of CN¥-425.23 Million could theoretically repay 0% of its total liabilities (CN¥29.01 Billion) in one year. See China National Accord Medicines Corp Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
China National Accord Medicines Corp Ltd Cash Flow-to-Debt Ratio (1998–2024)
Historical debt coverage capacity for China National Accord Medicines Corp Ltd across 27 annual periods. For the full cash flow conversion analysis, see cash flow conversion of China National Accord Medicines Corp Ltd.
Annual Cash Flow-to-Debt Ratio for China National Accord Medicines Corp Ltd (1998–2024)
Year-by-year debt coverage analysis for China National Accord Medicines Corp Ltd. Check China National Accord Medicines Corp Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.12x | CN¥3.27 Billion | CN¥26.80 Billion | ▲ +10.5% |
| 2023 | 0.11x | CN¥2.94 Billion | CN¥26.59 Billion | ▼ 0.0% |
| 2022 | 0.11x | CN¥2.56 Billion | CN¥23.17 Billion | ▲ +65.3% |
| 2021 | 0.07x | CN¥1.66 Billion | CN¥24.76 Billion | ▲ +1.0% |
| 2020 | 0.07x | CN¥1.50 Billion | CN¥22.71 Billion | ▼ -39.9% |
| 2019 | 0.11x | CN¥2.00 Billion | CN¥18.16 Billion | ▲ +25.1% |
| 2018 | 0.09x | CN¥1.32 Billion | CN¥15.02 Billion | ▼ -15.0% |
| 2017 | 0.10x | CN¥1.29 Billion | CN¥12.42 Billion | ▼ -12.8% |
| 2016 | 0.12x | CN¥1.47 Billion | CN¥12.40 Billion | ▼ -13.3% |
| 2015 | 0.14x | CN¥1.05 Billion | CN¥7.65 Billion | ▲ +237.1% |
| 2014 | -0.10x | CN¥-796.70 Million | CN¥7.98 Billion | ▼ -287.7% |
| 2013 | 0.05x | CN¥465.03 Million | CN¥8.74 Billion | ▲ +22.5% |
| 2012 | 0.04x | CN¥323.96 Million | CN¥7.46 Billion | ▲ +19.2% |
| 2011 | 0.04x | CN¥227.32 Million | CN¥6.24 Billion | ▼ -56.0% |
| 2010 | 0.08x | CN¥428.16 Million | CN¥5.18 Billion | ▲ +33.0% |
| 2009 | 0.06x | CN¥270.85 Million | CN¥4.36 Billion | ▼ -23.5% |
| 2008 | 0.08x | CN¥246.58 Million | CN¥3.03 Billion | ▲ +121.3% |
| 2007 | 0.04x | CN¥87.70 Million | CN¥2.39 Billion | ▼ -55.4% |
| 2006 | 0.08x | CN¥181.73 Million | CN¥2.21 Billion | ▼ -62.3% |
| 2005 | 0.22x | CN¥148.28 Million | CN¥678.73 Million | ▼ -18.2% |
| 2004 | 0.27x | CN¥130.30 Million | CN¥487.99 Million | ▲ +118.8% |
| 2003 | 0.12x | CN¥81.22 Million | CN¥665.47 Million | ▲ +204.6% |
| 2002 | 0.04x | CN¥28.76 Million | CN¥717.90 Million | ▼ -57.6% |
| 2001 | 0.09x | CN¥71.16 Million | CN¥753.72 Million | ▼ -4.9% |
| 2000 | 0.10x | CN¥8.52 Million | CN¥85.83 Million | ▼ -62.3% |
| 1999 | 0.26x | CN¥22.84 Million | CN¥86.72 Million | ▲ +477.0% |
| 1998 | 0.05x | CN¥5.21 Million | CN¥114.11 Million | — |